Eli Lilly CEO Dave Ricks said one-third of new GLP-1 pill patients are starting on the company's oral drug Foundayo. He spoke as the drugmaker broke ground on a new manufacturing site in Houston, ...
Wall Street impressed with initial prescriptions for Lilly's Foundayo Lilly cautions early weekly figures may not be fully comprehensive Demand for Novo Nordisk's oral Wegovy also strong April 17 ...
The FDA approved a GLP-1 pill from Eli Lilly called Foundayo. Foundayo isn't as effective as Lilly's weekly shot Zepbound, but the once-daily pill could be attractive for people looking for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results